Article Versions Notes

Parvathareddy V, Selamet U, Sen AA, Mamlouk O, Song J, Page VD, Abdelrahim M, Diab A, Abdel-Wahab N, Abudayyeh A. Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response. Cancers. 2023; 15(21):5181. https://doi.org/10.3390/cancers15215181

Parvathareddy, Vishnupriyadevi, Umut Selamet, Aditi A. Sen, Omar Mamlouk, Juhee Song, Valda D. Page, Maen Abdelrahim, Adi Diab, Noha Abdel-Wahab, and Ala Abudayyeh. 2023. "Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response" Cancers 15, no. 21: 5181. https://doi.org/10.3390/cancers15215181

Parvathareddy, V., Selamet, U., Sen, A. A., Mamlouk, O., Song, J., Page, V. D., Abdelrahim, M., Diab, A., Abdel-Wahab, N., & Abudayyeh, A. (2023). Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response. Cancers, 15(21), 5181. https://doi.org/10.3390/cancers15215181